Cite
MLA Citation
Richard J Russell et al.. “Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial.” Lancet, vol. 6, no. 7, 2018, pp. 499–510. http://access.bl.uk/ark:/81055/vdc_100066409609.0x000007